269 related articles for article (PubMed ID: 31829141)
1. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study.
Digby J; Strachan JA; Mowat C; Steele RJC; Fraser CG
BMC Gastroenterol; 2019 Dec; 19(1):213. PubMed ID: 31829141
[TBL] [Abstract][Full Text] [Related]
2. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
[TBL] [Abstract][Full Text] [Related]
3. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
[TBL] [Abstract][Full Text] [Related]
4. Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: a prospective cohort study.
Mowat C; Digby J; Strachan JA; McCann R; Hall C; Heather D; Carey F; Fraser CG; Steele RJC
BMJ Open Gastroenterol; 2019; 6(1):e000293. PubMed ID: 31275586
[TBL] [Abstract][Full Text] [Related]
5. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
[TBL] [Abstract][Full Text] [Related]
6. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
7. Faecal haemoglobin concentration in adenoma, before and after polypectomy, approaches the ideal tumour marker.
Mowat C; Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJ; Strachan JA; Humphries A; Fraser CG
Ann Clin Biochem; 2022 Jul; 59(4):272-276. PubMed ID: 35235491
[TBL] [Abstract][Full Text] [Related]
8. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR
Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776
[TBL] [Abstract][Full Text] [Related]
9. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911
[TBL] [Abstract][Full Text] [Related]
10. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
[TBL] [Abstract][Full Text] [Related]
11. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.
Senore C; Zappa M; Campari C; Crotta S; Armaroli P; Arrigoni A; Cassoni P; Colla R; Fracchia M; Gili F; Grazzini G; Lolli R; Menozzi P; Orione L; Polizzi S; Rapi S; Riggi E; Rubeca T; Sassatelli R; Visioli C; Segnan N
Gut; 2020 Mar; 69(3):523-530. PubMed ID: 31455608
[TBL] [Abstract][Full Text] [Related]
12. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems.
Benton SC; Piggott C; Zahoor Z; O'Driscoll S; Fraser CG; D'Souza N; Chen M; Georgiou Delisle T; Abulafi M
Clin Chem Lab Med; 2022 Jul; 60(8):1278-1286. PubMed ID: 35637625
[TBL] [Abstract][Full Text] [Related]
14. Do risk scores improve use of faecal immunochemical testing for haemoglobin in symptomatic patients in primary care?
Digby J; Fraser CG; Clark G; Mowat C; Strachan JA; Steele RJC
Colorectal Dis; 2024 Apr; 26(4):675-683. PubMed ID: 38424669
[TBL] [Abstract][Full Text] [Related]
15. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold.
Young GP; Woodman RJ; Symonds E
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32994195
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
17. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges.
Fraser CG
Surgeon; 2018 Oct; 16(5):302-308. PubMed ID: 29548552
[TBL] [Abstract][Full Text] [Related]
18. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.
Digby J; Fraser CG; Carey FA; Lang J; Stanners G; Steele RJ
J Med Screen; 2016 Sep; 23(3):130-4. PubMed ID: 26589788
[TBL] [Abstract][Full Text] [Related]
19. Faecal calprotectin is not necessarily required as a screen for significant bowel disease in primary care.
Waite MMA; Langmead L; Ayling RM
Ann Clin Biochem; 2022 May; 59(3):171-177. PubMed ID: 34958262
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic accuracy of the faecal immunohistochemical test in identifying significant bowel disease in a symptomatic population.
MacDonald S; MacDonald L; Godwin J; Macdonald A; Thornton M
Colorectal Dis; 2022 Mar; 24(3):257-263. PubMed ID: 34797583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
